Regulus Therapeutics Inc

Regulus Therapeutics Inc is an American clinical-stage biopharmaceutical company dedicated to discovering and developing RNA-targeted therapeutics. Its primary aim is to address serious diseases where there is a significant unmet medical need for patients. It operates in the United States. Operating within the biotechnology sector, Regulus Therapeutics Inc specialises in developing microRNA medicines. These therapies are designed to modulate microRNA activity, aiming to provide new treatment options for serious diseases, including kidney disorders. Monitor the RGLS share price by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.